Twist1 Overexpression Models an Aggressive Subtype of Pancreatic Ductal Adenocarcinoma in vivo
Single-cell RNA-seq · mouse · 25 samples
- What it is
- Single-cell RNA-seqGene activity measured in thousands of individual cells, so cell types can be told apart. Read from the summary: GEO's own type field only says 'expression profiling by sequencing', so confirm it in the paper.
- Organism
- Mus musculus (mouse)
- Samples
- 25 samples: 5 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE291909_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Single-cell studies usually ship their counts as 10x files (matrix.mtx, barcodes.tsv, features.tsv), an .h5 file, or an .rds / .h5ad object that Seurat or Scanpy can open. Look for those among the supplementary files.
Also filed as BioProject PRJNA1235761 and SRA study SRP570342. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 25 samples.
How we read this: 5 replicated groups read from 25 sample titles; they account for 25 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8844241 Twist1 Overexpression,rep 1 Twist1 Overexpression,
- GSM8844242 Twist1 Overexpression,rep 2 Twist1 Overexpression,
- GSM8844243 Twist1 Overexpression,rep 3 Twist1 Overexpression,
- GSM8844244 Twist1 Overexpression,rep 4 Twist1 Overexpression,
- GSM8844245 KrasG12D,rep1 KrasG12D,
- GSM8844246 KrasG12D,rep2 KrasG12D,
- GSM8844247 KrasG12D,rep3 KrasG12D,
- GSM8844248 KrasG12D+Twist1 overexpression Early,rep1 KrasG12D+Twist1 overexp…
- GSM8844249 KrasG12D+Twist1 overexpression Early,rep2 KrasG12D+Twist1 overexp…
- GSM8844250 KrasG12D+Twist1 overexpression Early,rep3 KrasG12D+Twist1 overexp…
- GSM8844251 KrasG12D+Twist1 overexpression Late,rep1 KrasG12D+Twist1 overexp…
- GSM8844252 KrasG12D+Twist1 overexpression Late,rep2 KrasG12D+Twist1 overexp…
- GSM8844253 KrasG12D+Twist1 overexpression Late,rep3 KrasG12D+Twist1 overexp…
- GSM8844254 KrasG12D+Twist1 overexpression Late,rep4 KrasG12D+Twist1 overexp…
- GSM8844255 KrasG12D+Twist1 overexpression Late,rep5 KrasG12D+Twist1 overexp…
- GSM8844256 KrasG12D+Twist1 overexpression Late,rep6 KrasG12D+Twist1 overexp…
- GSM8844257 KrasG12D+Twist1 overexpression Late,rep7 KrasG12D+Twist1 overexp…
- GSM8844258 KrasG12D+Twist1 overexpression Late,rep8 KrasG12D+Twist1 overexp…
- GSM8844259 KrasG12D+Twist1 overexpression Late,rep9 KrasG12D+Twist1 overexp…
- GSM8844260 KrasG12D+Trp53R172H,rep1 KrasG12D+Trp53R172H,
- GSM8844261 KrasG12D+Trp53R172H,rep2 KrasG12D+Trp53R172H,
- GSM8844262 KrasG12D+Trp53R172H,rep3 KrasG12D+Trp53R172H,
- GSM8844263 KrasG12D+Trp53R172H,rep4 KrasG12D+Trp53R172H,
- GSM8844264 KrasG12D+Trp53R172H,rep5 KrasG12D+Trp53R172H,
- GSM8844265 KrasG12D+Trp53R172H,rep6 KrasG12D+Trp53R172H,
- GSE248585 A conserved epithelial wound-like transcriptional program driven by FOSL1 underlies malignant progression of pancreatic ductal adenocarcinoma (ssRNA-Seq) 46 samples shares adenocarcinoma, pancreatic, ductal
- GSE277392 Kras loss of heterozygosity promotes MAPK dependent pancreatic ductal adenocarcinoma and induces therapeutic sensitivity 31 samples shares adenocarcinoma, pancreatic, ductal
- GSE264009 Distance-depending transcriptome changes of pancreatic stellate cells in paracrine pancreatic ductal adenocarcinoma co-culture models 24 samples shares adenocarcinoma, pancreatic, ductal
- GSE264527 Reshaping the Tumor Microenvironment of KRASG12D Pancreatic Ductal Adenocarcinoma with combined SOS1 and MEK Inhibition for Improved Immunotherapy Response 21 samples shares adenocarcinoma, pancreatic, ductal
- GSE262879 Single-cell RNA-sequencing of murine pancreatic tumors derived from the orthotopic transplantation of Smad4 wild-type (WT) or Smad4 knockout (KO) pancreatic ductal adenocarcinoma (PDAC) KPC organoids in nu/nu mice. 18 samples shares adenocarcinoma, pancreatic, ductal
- GSE269680 CDK8 remodels the tumor microenvironment to resist the therapeutic efficacy of targeted KRASG12D inhibition in pancreatic ductal adenocarcinoma (spatial) 15 samples shares adenocarcinoma, pancreatic, ductal
- GSE330243 GATA4 loss promotes mutant Kras-driven pancreatic ductal adenocarcinoma in the absence of canonical precursor lesions [bulk RNA-Seq] 12 samples shares adenocarcinoma, pancreatic, ductal
- GSE331086 The CD49b (ITGA2) Collagen Receptor Excludes CD8+ T Cell Infiltration in Pancreatic Ductal Adenocarcinoma (PDAC) 9 samples shares adenocarcinoma, pancreatic, ductal
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.